iBio Inc (IBIO)

[ShinSekai]

I can't take this anymore. Most of, if not everyone here is misinformed. I will try to explain as succinctly as possible. Firstly, we are not the only company that holds patents for this technology in the EU, Americas and Asia. Secondly, we are not the first. Thirdly, we do however hold the key to the most efficient and productive technology. Our company has not lied about that fact. Mapp has stated in a 10/10/14 news release that they are IN FACT working with other PMP manufacturers in an attempt to maximimze the yield of protein mono clonal anti-bodies. Here is a quote, "Improving expression of the antibodies in Nicotiana. With internal resources, Mapp and KBP, together with other companies involved in PMPs, have been evaluating different
methods of improving the amount of antibody made in each plant."
http://mappbio.com/10-update.pdf

WE HOLD THE ONLY PMP TECHNOLOGY WITH A PATENT THAT EXPOUNDS THEREIN THE INCREASED PRODUCTION YIELD CAPABILITIES OF THE PROCESS! OH CALIBER YOU SAY? WELL CALIBER HAS ZERO I REPEAT ZERO PATENT PROTECTION FOR USING PMP's. THEY ARE AN IN-LICENSING COMPANY READ THEIR WEBSITE! http://www.caliberbio.com/licensing.html CLEARLY SAYS IN-LICENSING "In-licensing vector systems for plant-made pharmaceuticals (PMP)" THE ONLY WAY FOR THEM TO USE PMP IS THROUGH KBP OR US.
MEDICAGO HAS VLP'S. Mabs ARE NOT VLP'S. THEY'RE Mabs. THIS RULES OUT THE ONLY COMPETITION OUTSIDE OF KENTUCKY BIOPROCESSING WHOM MAPP IS ALREADY WORKING WITH. THEY ARE OUR ONLY COMPETITION, BUT THEY ARE SLOW!

Now this doesn't mean we have a license agreement. This is an emergency situation. Our companies Leaders sit on the board of novici who is also working to accelerate the process of protein manufacturing. My guess is that at any point in this emergency situation we could have loaned them our tech through a private agreement that does not have to be reported. Using that quote alone, we can pretty much throw all of these frivilous lawsuits out the window. If you lost money you were speculating and obviously didn't know what you owned. I feel no remorse for those who lost money.
So using what I've learned from hours and hours of doing DD, I will say that our competitors have either failed at the process, or they are extremely slow. That leaves us with the best means to manufacture the drug. Think about how our patents differ from the others. We utilize two viruses instead of one (Dual Vectors). You would think this would create complications. Maybe during its inception, but in the end it gave us the most efficeint means of production coupled with the highest yield. We'er in a great position right now. Our Board members are on key patents, including key GRAMMR patents(Fitzmaurice, Padgett, Novici) that Mapp is using. I don't know about you guys, but I sense a shift happening because this disruptive technology was uncovered. Amgen just laid off a thousand eployees. It wasn't a coincidence. I've said it a hundred times, "This Technology is The Future!" Our company is the only one that offers implementation assistance to other companies. WHAT DOES THAT TELL YOU? Everything screams patent disputes to me and we have a USPTO genius on our side and I think this attack could've been orchestrated by Mapp themselves. Our hands are tied because we would look ridiculous trying to sue the company trying to cure Ebola. Effectively, delaying the cure because of litigation. THAT IS WHY I SAY WE WILL BE ACQIURED EVENTUALLY. Watch the stock as it free falls and try to find the bottom is the only thing you can do.